Healio

FDA approves rechargeable DBS device for patients with movement disorders

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a rechargeable deep brain stimulation device with remote programming for individuals living ...
Benzinga.com

World's Smallest Brain Stimulation Device For Movement Disorder: FDA Approved Abbott's Liberta RC DBS system

Abbott Laboratories (NYSE:ABT) received FDA approval to launch the Liberta RC DBS system, the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people ...
Nasdaq

Medtronic's (MDT) Percept RC DBS System Secures FDA Approval

Medtronic plc MDT recently received the FDA’s approval for the Percept RC Deep Brain Stimulation (“DBS”) system. The rechargeable neurostimulator is the latest innovation in the Medtronic Percept ...
Healio

Patent awarded to neurohealth firm for non-invasive, frequency-based DBS device

Please provide your email address to receive an email when new articles are posted on . A Houston-based neurohealth company has received a patent for its non-invasive, frequency-based deep brain ...
UPI

'Breakthrough' deep brain stimulation device for Parkinson's to make clinical debut

ST. PAUL, Minn., March 21 (UPI) --Parkinson's disease patients and advocates are marking the start of a new era for treatment of the illness, as a doctors deploy a breakthrough neurological device for ...
Longview News-Journal

Newronika Receives Investigational Device Exemption (IDE) from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System

MILAN, Feb. 5, 2025 /PRNewswire/ -- Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption (IDE) ...